Brown, C. M., Ray, M., Eroy-Reveles, A. A., Egea, P., Tajon, C., & Craik, C. S. (2011). Peptide length and prime-side sterics influence potency of peptide phosphonate protease inhibitors.
Chicago-stil citatBrown, Christopher M., Manisha Ray, Aura A. Eroy-Reveles, Pascal Egea, Cheryl Tajon, och Charles S. Craik. Peptide Length and Prime-side Sterics Influence Potency of Peptide Phosphonate Protease Inhibitors. 2011.
MLA-referensBrown, Christopher M., et al. Peptide Length and Prime-side Sterics Influence Potency of Peptide Phosphonate Protease Inhibitors. 2011.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.